These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 3746800)

  • 1. Cardiovascular risk in patients with treated familial hypercholesterolaemia and patients with severe hypertriglyceridaemia.
    Way BP; Ball MJ; Thorogood M; Cobbe SM; Mann JI
    J R Soc Med; 1986 Jul; 79(7):391-4. PubMed ID: 3746800
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of the risk of fatal coronary heart disease in treated xanthomatous and non-xanthomatous heterozygous familial hypercholesterolaemia: a prospective registry study.
    Neil HA; Huxley RR; Hawkins MM; Durrington PN; Betteridge DJ; Humphries SE;
    Atherosclerosis; 2003 Sep; 170(1):73-8. PubMed ID: 12957684
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The 'midband' lipoprotein is a coronary risk factor in Japanese patients with familial hypercholesterolaemia.
    Tashiro J; Nishide T; Shinomiya M; Shirai K; Saito Y; Yoshida S; Yamashita M; Ohshima H; Murayama H
    Scand J Clin Lab Invest; 1993 Jul; 53(4):335-8. PubMed ID: 8378736
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Musculoskeletal symptoms in patients with primary hyperlipoproteinemia. A prelimary study].
    Brekke SE; Kogstad OA
    Tidsskr Nor Laegeforen; 1979 Oct; 99(29):1444-6. PubMed ID: 516016
    [No Abstract]   [Full Text] [Related]  

  • 5. Mortality in treated heterozygous familial hypercholesterolaemia: implications for clinical management. Scientific Steering Committee on behalf of the Simon Broome Register Group.
    Atherosclerosis; 1999 Jan; 142(1):105-12. PubMed ID: 9920511
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Blood lipids as a factor of hereditary susceptibility to ischemic heart disease].
    Raĭkov AN; Khalfen ESh; Koshechkin VA; Sokolova MA
    Kardiologiia; 1989 Jun; 29(6):14-9. PubMed ID: 2779072
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term efficacy of low-density lipoprotein apheresis on coronary heart disease in familial hypercholesterolemia. Hokuriku-FH-LDL-Apheresis Study Group.
    Mabuchi H; Koizumi J; Shimizu M; Kajinami K; Miyamoto S; Ueda K; Takegoshi T
    Am J Cardiol; 1998 Dec; 82(12):1489-95. PubMed ID: 9874053
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risk of fatal coronary heart disease in familial hypercholesterolaemia. Scientific Steering Committee on behalf of the Simon Broome Register Group.
    BMJ; 1991 Oct; 303(6807):893-6. PubMed ID: 1933004
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Differential use of diet and drugs in dyslipoproteinemias].
    Lipovetskiĭ BM; Triufanov VF; Teriukova NP
    Klin Med (Mosk); 1985 Jan; 63(1):116-20. PubMed ID: 3990175
    [No Abstract]   [Full Text] [Related]  

  • 10. Importance of LDL/HDL cholesterol ratio as a predictor for coronary heart disease events in patients with heterozygous familial hypercholesterolaemia: a 15-year follow-up (1987-2002).
    Panagiotakos DB; Pitsavos C; Skoumas J; Chrysohoou C; Toutouza M; Stefanadis CI; Toutouzas PK
    Curr Med Res Opin; 2003; 19(2):89-94. PubMed ID: 12755140
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Comparative analysis of incidence of main risk factors, behavior characteristics and work activity in ischemic heart disease with normolipemia and hyperlipoproteinemia type II and IV].
    Ganelina IE; Krivoruchenko IV; Kruchinina IA; Pritykina NIa; Chernigovskaia SV
    Kardiologiia; 1979 Aug; 19(8):78-82. PubMed ID: 226766
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Importance of HDL cholesterol levels and the total/ HDL cholesterol ratio as a risk factor for coronary heart disease in molecularly defined heterozygous familial hypercholesterolaemia.
    Real JT; Chaves FJ; Martínez-Usó I; García-García AB; Ascaso JF; Carmena R
    Eur Heart J; 2001 Mar; 22(6):465-71. PubMed ID: 11237541
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The type of mutation in the low density lipoprotein receptor gene influences the cholesterol-lowering response of the HMG-CoA reductase inhibitor simvastatin in patients with heterozygous familial hypercholesterolaemia.
    Heath KE; Gudnason V; Humphries SE; Seed M
    Atherosclerosis; 1999 Mar; 143(1):41-54. PubMed ID: 10208479
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Localization of vessel lesions in arteriosclerosis and blood lipid composition].
    Lipovetskiĭ BM; Vinogradova TV
    Ter Arkh; 2002; 74(2):55-7. PubMed ID: 11899828
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mutational analysis in UK patients with a clinical diagnosis of familial hypercholesterolaemia: relationship with plasma lipid traits, heart disease risk and utility in relative tracing.
    Humphries SE; Cranston T; Allen M; Middleton-Price H; Fernandez MC; Senior V; Hawe E; Iversen A; Wray R; Crook MA; Wierzbicki AS
    J Mol Med (Berl); 2006 Mar; 84(3):203-14. PubMed ID: 16389549
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Incidence of familial hypercholesterolaemia in premature deaths due to coronary heart disease.
    Leadbeatter S; Williams DW; Stansbie D
    Am J Forensic Med Pathol; 1987 Dec; 8(4):280-2. PubMed ID: 3434546
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevalence of hypercholesterolaemia in young Afrikaners undergoing coronary artery bypass surgery. Ischaemic heart disease risk factors.
    Seftel HC; Wyndham CH; dos Santos LA; Pilcher GJ; Baker SG
    S Afr Med J; 1987 Feb; 71(3):142-4. PubMed ID: 3492769
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Perspectives in familial hypercholesterolemia: with particular reference to associated ischemic heart disease].
    Miida T; Aizawa Y; Yamazoe M; Shibata A
    J Cardiol; 1988 Dec; 18(4):1007-13. PubMed ID: 3267710
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mutations of low-density-lipoprotein-receptor gene, variation in plasma cholesterol, and expression of coronary heart disease in homozygous familial hypercholesterolaemia.
    Moorjani S; Roy M; Torres A; Bétard C; Gagné C; Lambert M; Brun D; Davignon J; Lupien P
    Lancet; 1993 May; 341(8856):1303-6. PubMed ID: 8098448
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Platelets intravascular coagulation and fibrinolysis in hyperlipidaemias: relationship to thrombo-embolic complications.
    Carvalho AC; Lees RS
    Acta Med Scand Suppl; 1980; 642():101-12. PubMed ID: 6935936
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.